Published in J Immunol on January 15, 2001
CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med (2007) 4.66
IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage. J Clin Invest (2004) 3.69
The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J Exp Med (2001) 3.63
IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol (2002) 3.44
Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med (2004) 2.57
A role for IgG immune complexes during infection with the intracellular pathogen Leishmania. J Exp Med (2005) 2.50
NF-kappaB1 (p50) homodimers differentially regulate pro- and anti-inflammatory cytokines in macrophages. J Biol Chem (2006) 2.29
Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis (2010) 2.24
CCR5-dependent homing of naturally occurring CD4+ regulatory T cells to sites of Leishmania major infection favors pathogen persistence. J Exp Med (2006) 1.88
Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect Immun (2002) 1.85
Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis. Infect Immun (2003) 1.74
Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect Immun (2004) 1.65
Uptake of Leishmania major by dendritic cells is mediated by Fcgamma receptors and facilitates acquisition of protective immunity. J Exp Med (2006) 1.59
Regulatory role of T cells producing both interferon gamma and interleukin 10 in persistent infection. J Exp Med (2001) 1.57
Dynamic and transient remodeling of the macrophage IL-10 promoter during transcription. J Immunol (2006) 1.55
Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect Immun (2002) 1.54
Autocrine IL-10 induces hallmarks of alternative activation in macrophages and suppresses antituberculosis effector mechanisms without compromising T cell immunity. J Immunol (2009) 1.47
Macrophage cytokines: involvement in immunity and infectious diseases. Front Immunol (2014) 1.44
Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis. Infect Immun (2003) 1.38
IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J Clin Invest (2003) 1.36
Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect Immun (2004) 1.35
Enhanced replication of Leishmania amazonensis amastigotes in gamma interferon-stimulated murine macrophages: implications for the pathogenesis of cutaneous leishmaniasis. Infect Immun (2004) 1.33
Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol (2007) 1.22
Leishmania donovani infection down-regulates TLR2-stimulated IL-12p40 and activates IL-10 in cells of macrophage/monocytic lineage by modulating MAPK pathways through a contact-dependent mechanism. Clin Exp Immunol (2008) 1.21
L-arginine metabolism and its impact on host immunity against Leishmania infection. Immunol Res (2008) 1.21
Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol Immunol (2008) 1.20
Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions. Infect Immun (2005) 1.18
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Int J Parasitol (2007) 1.17
Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens. Infect Immun (2011) 1.16
Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection. Infect Immun (2003) 1.16
IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection. PLoS Pathog (2013) 1.15
Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol (2007) 1.15
Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines. PLoS Negl Trop Dis (2010) 1.14
A B lymphocyte mitogen is a Brucella abortus virulence factor required for persistent infection. Proc Natl Acad Sci U S A (2006) 1.13
FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions. Infect Immun (2007) 1.10
Immunobiology of visceral leishmaniasis. Front Immunol (2012) 1.10
CXCL10/gamma interferon-inducible protein 10-mediated protection against Leishmania amazonensis infection in mice. Infect Immun (2006) 1.09
Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection. PLoS Pathog (2007) 1.09
The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response. Front Cell Infect Microbiol (2012) 1.08
L-arginine and cationic amino acid transporter 2B regulate growth and survival of Leishmania amazonensis amastigotes in macrophages. Infect Immun (2007) 1.08
Immunological perspectives of leishmaniasis. J Glob Infect Dis (2010) 1.08
The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10. Infect Immun (2003) 1.07
Regulation of CD8+ T cell responses to infection with parasitic protozoa. Exp Parasitol (2010) 1.04
Immunity to Lutzomyia intermedia saliva modulates the inflammatory environment induced by Leishmania braziliensis. PLoS Negl Trop Dis (2010) 1.02
Leishmania interferes with host cell signaling to devise a survival strategy. J Biomed Biotechnol (2010) 1.01
Regulatory T cells suppress T cell activation at the pathologic site of human visceral leishmaniasis. PLoS One (2012) 1.00
Suppression of LPS-induced inflammatory responses in macrophages infected with Leishmania. J Inflamm (Lond) (2010) 1.00
Leishmania major amastigotes induce p50/c-Rel NF-kappa B transcription factor in human macrophages: involvement in cytokine synthesis. Infect Immun (2004) 0.99
Does T Helper Differentiation Correlate with Resistance or Susceptibility to Infection with L. major? Some Insights From the Murine Model. Front Immunol (2012) 0.98
T helper1/t helper2 cells and resistance/susceptibility to leishmania infection: is this paradigm still relevant? Front Immunol (2012) 0.98
Activation of PI3K/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol (2008) 0.98
Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect Immun (2002) 0.97
NK cells in gamma-interferon-deficient mice suppress lung innate immunity against Mycoplasma spp. Infect Immun (2005) 0.96
Upregulated expression of B-cell antigen family tandem repeat proteins by Leishmania amastigotes. Infect Immun (2010) 0.95
Sex hormones and modulation of immunity against leishmaniasis. Neuroimmunomodulation (2009) 0.94
Immunomodulatory effects of the Lutzomyia longipalpis salivary gland protein maxadilan on mouse macrophages. Infect Immun (2007) 0.94
Parasite-derived arginase influences secondary anti-Leishmania immunity by regulating programmed cell death-1-mediated CD4+ T cell exhaustion. J Immunol (2013) 0.94
mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection. Med Microbiol Immunol (2011) 0.93
Regulation of immunity during visceral Leishmania infection. Parasit Vectors (2016) 0.92
Leishmania pifanoi proteoglycolipid complex P8 induces macrophage cytokine production through Toll-like receptor 4. Infect Immun (2008) 0.92
Inhibition of receptor tyrosine kinases restores immunocompetence and improves immune-dependent chemotherapy against experimental leishmaniasis in mice. J Clin Invest (2010) 0.92
Adjuvants for Leishmania vaccines: from models to clinical application. Front Immunol (2012) 0.92
Toll-like receptors participate in macrophage activation and intracellular control of Leishmania (Viannia) panamensis. Infect Immun (2011) 0.91
Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice. Parasite Immunol (2014) 0.91
Leishmania mexicana promastigotes inhibit macrophage IL-12 production via TLR-4 dependent COX-2, iNOS and arginase-1 expression. Mol Immunol (2011) 0.90
Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection. Vaccine (2009) 0.90
Effects of CXCL10 on dendritic cell and CD4+ T-cell functions during Leishmania amazonensis infection. Infect Immun (2007) 0.90
Antigen-experienced T cells limit the priming of naive T cells during infection with Leishmania major. J Immunol (2006) 0.89
Staphylococcus aureus phenol-soluble modulin peptides modulate dendritic cell functions and increase in vitro priming of regulatory T cells. J Immunol (2013) 0.89
Deletion of IL-4 receptor alpha on dendritic cells renders BALB/c mice hypersusceptible to Leishmania major infection. PLoS Pathog (2013) 0.89
Cutaneous leishmaniasis: immune responses in protection and pathogenesis. Nat Rev Immunol (2016) 0.88
Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection. Cell Microbiol (2011) 0.88
T cell-derived IL-10 determines leishmaniasis disease outcome and is suppressed by a dendritic cell based vaccine. PLoS Pathog (2013) 0.88
Infection-induced IL-10 and JAK-STAT: A review of the molecular circuitry controlling immune hyperactivity in response to pathogenic microbes. JAKSTAT (2012) 0.88
IgG1 is pathogenic in Leishmania mexicana infection. J Immunol (2010) 0.87
Effects of tropism and virulence of Leishmania parasites on cytokine production by infected human monocytes. Clin Exp Immunol (2008) 0.87
CD4+ T Cells: guardians of the phagosome. Clin Microbiol Rev (2014) 0.87
A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin. Immunology (2007) 0.86
CD8+ T cells in cutaneous leishmaniasis: the good, the bad, and the ugly. Semin Immunopathol (2015) 0.86
Soluble CD26/CD30 levels in visceral leishmaniasis: markers of disease activity. Clin Exp Immunol (2006) 0.85
Exploring the role of medicinal plant-based immunomodulators for effective therapy of leishmaniasis. Front Immunol (2014) 0.85
What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis. Med Microbiol Immunol (2009) 0.85
Berberine chloride mediates its anti-leishmanial activity via differential regulation of the mitogen activated protein kinase pathway in macrophages. PLoS One (2011) 0.85
Transcriptional inhibition of interleukin-12 promoter activity in Leishmania spp.-infected macrophages. J Parasitol (2008) 0.85
Genomic analysis of LPS-stimulated myeloid cells identifies a common pro-inflammatory response but divergent IL-10 anti-inflammatory responses. Sci Rep (2015) 0.85
UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J Biol Chem (2013) 0.85
Alternatively Activated Macrophages Revisited: New Insights into the Regulation of Immunity, Inflammation and Metabolic Function following Parasite Infection. Curr Immunol Rev (2013) 0.84
Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani. J Trop Med (2011) 0.84
Mononuclear cells from patients recovered from cutaneous leishmaniasis respond to Leishmania major amastigote class I nuclease with a predominant Th1-like response. Clin Exp Immunol (2005) 0.84
Role of co-stimulation in Leishmaniasis. Int J Biol Sci (2011) 0.83
Biased cellular locations of tandem repeat antigens in African trypanosomes. Biochem Biophys Res Commun (2011) 0.83
Legionella pneumophila evades gamma interferon-mediated growth suppression through interleukin-10 induction in bone marrow-derived macrophages. Infect Immun (2005) 0.83
The PGE2/IL-10 Axis Determines Susceptibility of B-1 Cell-Derived Phagocytes (B-1CDP) to Leishmania major Infection. PLoS One (2015) 0.83
Natural killer cells in experimental and human leishmaniasis. Front Cell Infect Microbiol (2012) 0.82
A Petri net model of granulomatous inflammation: implications for IL-10 mediated control of Leishmania donovani infection. PLoS Comput Biol (2013) 0.82
Inbred strains derived from feral mice reveal new pathogenic mechanisms of experimental leishmaniasis due to Leishmania major. Infect Immun (2004) 0.82
BALB/c mice vaccinated with Leishmania major ribosomal proteins extracts combined with CpG oligodeoxynucleotides become resistant to disease caused by a secondary parasite challenge. J Biomed Biotechnol (2010) 0.81
Evaluation of T cell responses in healing and nonhealing leishmaniasis reveals differences in T helper cell polarization ex vivo and in vitro. Parasite Immunol (2009) 0.81
The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes. J Immunol (1985) 2.63
Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med (1998) 2.55
Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol (2001) 2.49
Macrophage activation by endogenous danger signals. J Pathol (2008) 2.38
Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med (1997) 2.31
The third component of complement (C3) is responsible for the intracellular survival of Leishmania major. Nature (1987) 1.78
Role of the Leishmania surface protease gp63 in complement fixation, cell adhesion, and resistance to complement-mediated lysis. J Immunol (1995) 1.77
Survival and replication of Rhodococcus equi in macrophages. Infect Immun (1994) 1.76
Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect Immun (1999) 1.73
Activation of the alternative complement pathway by Leishmania promastigotes: parasite lysis and attachment to macrophages. J Immunol (1984) 1.66
A heparin-binding activity on Leishmania amastigotes which mediates adhesion to cellular proteoglycans. J Cell Biol (1993) 1.57
Production of a hemolytic factor by Candida albicans. Infect Immun (1994) 1.43
Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol (2001) 1.29
Immunosuppression induced by attenuated Salmonella. Evidence for mediation by macrophage precursors. J Immunol (1991) 1.23
Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun (1999) 1.17
Role of complement in mouse macrophage binding of Haemophilus influenzae type b. J Clin Invest (1990) 1.16
Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun (2000) 1.14
Leishmania parasites and their ploys to disrupt macrophage activation. Curr Opin Hematol (2000) 1.13
The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect Immun (1993) 1.11
Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3. J Immunol (1985) 1.10
Cooperation between CR1 (CD35) and CR3 (CD 11b/CD18) in the binding of complement-opsonized particles. J Leukoc Biol (1996) 1.09
Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts. J Exp Med (1987) 1.08
Leishmania species: mechanisms of complement activation by five strains of promastigotes. Exp Parasitol (1986) 1.07
High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages. J Infect Dis (1994) 1.04
Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion. Infect Immun (1996) 1.03
Leishmania amazonensis: the phagocytosis of amastigotes by macrophages. Exp Parasitol (1998) 1.00
High-molecular-weight proteins of nontypeable Haemophilus influenzae mediate bacterial adhesion to cellular proteoglycans. Infect Immun (1994) 1.00
A role for complement receptor-like molecules in iron acquisition by Candida albicans. J Exp Med (1992) 1.00
Morphine enhances interleukin-12 and the production of other pro-inflammatory cytokines in mouse peritoneal macrophages. J Leukoc Biol (2000) 0.99
Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors. Microbes Infect (2001) 0.97
Effect of amplification of the Cap b locus on complement-mediated bacteriolysis and opsonization of type b Haemophilus influenzae. Infect Immun (1996) 0.96
Trypanosoma brucei: recognition in vitro of two developmental forms by murine macrophages. Exp Parasitol (1982) 0.93
The taming of IL-12: suppressing the production of proinflammatory cytokines. J Leukoc Biol (1999) 0.93
Immunological characterization of eristostatin and echistatin binding sites on alpha IIb beta 3 and alpha V beta 3 integrins. Biochem J (1996) 0.92
Neutrophils have a protective role during early stages of Leishmania amazonensis infection in BALB/c mice. Parasite Immunol (2014) 0.91
Exploitation of the complement system by Leishmania promastigotes. Parasitol Today (1996) 0.91
An assay to quantitate the binding of Rhodococcus equi to macrophages. Vet Immunol Immunopathol (1992) 0.84
Vaccination against the intracellular pathogens Leishmania major and L. amazonensis by directing CD40 ligand to macrophages. Infect Immun (2001) 0.84
Mercury enhances susceptibility to murine leishmaniasis. Parasite Immunol (2001) 0.80
Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1. Blood (2000) 0.80
Kinetics of an experimental inflammatory reaction induced by Leishmania major during the implantation of paraffin tablets in mice. Virchows Arch (2000) 0.79
Platelet factor 4 efficiently reverses heparin anticoagulation in the rat without adverse effects of heparin-protamine complexes. Circulation (1992) 0.77
Activation of murine resident peritoneal macrophages by a cell wall extract of Candida albicans. J Med Vet Mycol (1996) 0.77
Mechanisms of microbial entry and endocytosis by mononuclear phagocytes. Contemp Top Immunobiol (1984) 0.75
Cloning and characterization of the ribosomal l11 gene from Leishmania spp. Mol Biochem Parasitol (1995) 0.75